Liquid Biopsy Market Worth 2.04 Billion USD by 2022
The report "Liquid Biopsy Market by Cancer Type (Lung, Breast, Colorectal, Prostate), Circulating Biomarkers (Circulating Tumor Cells, Circulating Tumor DNA, Cell-Free DNA), Product (Instruments, Assay Kits), End User (Reference Laboratory) - Global Forecast to 2022", The liquid biopsy market is expected to reach USD 2,047.9 Million by 2022 from an estimated USD 715.7 Million in 2017, at a CAGR of 23.4%. The key factors driving the growth of this market include increasing prevalence of cancer, increasing preference for noninvasive procedures,...
View full press release